Current Status of Gene Engineering Cell Therapeutics

por Saudemont, Aurore, Jespers, Laurent, Clay, Timothy
Publicado 2018

Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy

por Whiteside, Theresa L., Gulley, James L., Clay, Timothy M., Tsang, Kwong Yok
Publicado 2011

The impact of the 2022 Ukraine/Russian conflict on cancer clinical trials

por Talbot, Alice, Connor, Sophia G., Austin, Kate, Hannon, Tara, Gabbay, Eli, Clay, Timothy D.
Publicado 2022

Multiple stressors produce differential transcriptomic patterns in a stream-dwelling salamander

por Clay, Timothy A., Steffen, Michael A., Treglia, Michael L., Torres, Carolyn D., Trujano-Alvarez, Ana Lilia, Bonett, Ronald M.
Publicado 2019

Investigation of HIFU-induced anti-tumor immunity in a murine tumor model

por Hu, Zhenlin, Yang, Xiao Yi, Liu, Yunbo, Sankin, Georgy N, Pua, Eric C, Morse, Michael A, Lyerly, H Kim, Clay, Timothy M, Zhong, Pei
Publicado 2007

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

por Britten, Cedrik Michael, Janetzki, Sylvia, Ben-Porat, Leah, Clay, Timothy M., Kalos, Michael, Maecker, Holden, Odunsi, Kunle, Pride, Michael, Old, Lloyd, Hoos, Axel, Romero, Pedro
Publicado 2009

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2

por Morse, Michael A, Hobeika, Amy, Osada, Takuya, Niedzwiecki, Donna, Marcom, Paul Kelly, Blackwell, Kimberly L, Anders, Carey, Devi, Gayathri R, Lyerly, H Kim, Clay, Timothy M
Publicado 2007

Optimization of vaccine responses with an E1, E2b, E3 deleted Ad5 vector circumvents pre-existing anti-vector immunity

por Osada, Takuya, Yang, Xiao Yi, Hartman, Zachary C., Glass, Oliver, Hodges, Bradley L., Niedzwiecki, Donna, Morse, Michael A., Lyerly, H. Kim, Amalfitano, Andrea, Clay, Timothy M.
Publicado 2009

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

por Janetzki, Sylvia, Panageas, Katherine S., Ben-Porat, Leah, Boyer, Jean, Britten, Cedrik M., Clay, Timothy M., Kalos, Michael, Maecker, Holden T., Romero, Pedro, Yuan, Jianda, Martin Kast, W., Hoos, Axel
Publicado 2007

Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion

por Hamilton, Erika, Blackwell, Kimberly, Hobeika, Amy C, Clay, Timothy M, Broadwater, Gloria, Ren, Xiu-Rong, Chen, Wei, Castro, Henry, Lehmann, Frederic, Spector, Neil, Wei, Junping, Osada, Takuya, Lyerly, H Kim
Publicado 2012

Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistan...

por Osada, Takuya, Hartman, Zachary C., Wei, Junping, Lei, Gangjun, Hobeika, Amy C., Gwin, William R., Diniz, Marcio A., Spector, Neil, Clay, Timothy M., Chen, Wei, Morse, Michael A., Lyerly, H. Kim
Publicado 2018

Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion

por Hamilton, Erika, Blackwell, Kimberly, Hobeika, Amy C, Clay, Timothy M, Broadwater, Gloria, Ren, Xiu-Rong, Chen, Wei, Castro, Henry, Lehmann, Frederic, Spector, Neil, Wei, Junping, Osada, Takuya, Lyerly, H Kim, Morse, Michael A
Publicado 2013

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

por Morse, Michael A, Garst, Jennifer, Osada, Takuya, Khan, Shubi, Hobeika, Amy, Clay, Timothy M, Valente, Nancy, Shreeniwas, Revati, Sutton, Mary Ann, Delcayre, Alain, Hsu, Di-Hwei, Le Pecq, Jean-Bernard, Lyerly, H Kim
Publicado 2005

Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides

por Maecker, Holden T, Hassler, Jeffrey, Payne, Janice K, Summers, Amanda, Comatas, Karrie, Ghanayem, Manar, Morse, Michael A, Clay, Timothy M, Lyerly, Herbert K, Bhatia, Sonny, Ghanekar, Smita A, Maino, Vernon C, delaRosa, Corazon, Disis, Mary L
Publicado 2008

Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells

por Ren, Xiu-Rong, Wei, Junping, Lei, Gangjun, Wang, Jiangbo, Lu, Jiuyi, Xia, Wenle, Spector, Neil, Barak, Larry S, Clay, Timothy M, Osada, Takuya, Hamilton, Erika, Blackwell, Kimberly, Hobeika, Amy C, Morse, Michael A, Lyerly, H Kim, Chen, Wei
Publicado 2012

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT

por Maecker, Holden T, Moon, James, Bhatia, Sonny, Ghanekar, Smita A, Maino, Vernon C, Payne, Janice K, Kuus-Reichel, Kristine, Chang, Jennie C, Summers, Amanda, Clay, Timothy M, Morse, Michael A, Lyerly, H Kim, DeLaRosa, Corazon, Ankerst, Donna P, Disis, Mary L
Publicado 2005

Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System

por D’Amato, Nicholas C., Ostrander, Julie H., Bowie, Michelle L., Sistrunk, Christopher, Borowsky, Alexander, Cardiff, Robert D., Bell, Katie, Young, Lawrence J. T., Simin, Karl, Bachelder, Robin E., Delrow, Jeff, Dawson, Alyssa, Yee, Lisa D., Mrózek, Krzysztof, Clay, Timothy M., Osada, Takuya, Seewaldt, Victoria L.
Publicado 2012

Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in pat...

por Rudin, Charles M, Pandha, Hardev S, Zibelman, Matthew, Akerley, Wallace L, Harrington, Kevin J, Day, Daphne, Hill, Andrew G, O'Day, Steven J, Clay, Timothy D, Wright, Gavin M, Jennens, Ross R, Gerber, David E, Rosenberg, Jonathan E, Ralph, Christy, Campbell, David C, Curti, Brendan D, Merchan, Jaime R, Ren, Yixin, Schmidt, Emmett V, Guttman, Lisa, Gupta, Sumati
Publicado 2023